Home
Training 2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers
2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers
The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.
Learning Objectives:
List 3 examples of sexual history questions for each the “Five P’s” of sexual history taking
Explain why the treatment guidelines for both chlamydia and gonorrhea genital tract infections were updated in the 2021 Guidelines
List the indications for obtaining chlamydia and gonorrhea samples from the anus and the oropharynx
Describe the consequences of Mycoplasma genitalium genital infection in males and females
List 2 updates in the 2021 Guidelines regarding vaginal trichomoniasis
California Clinical Guidelines for Gonorrhea Treatment and Management of Suspected Treatment Failure
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
The California Department of Public Health (CDPH) has received increasing reports of disseminated gonococcal infection (DGI), a severe complication of untreated gonorrhea. Dr. Laura Quilter and Dr. Eric Tang discuss DGI epidemiology, clinical presentation, and management, and review California’s recent DGI investigation and what clinicians can do to help.
Drs. Quilter and Tang cover the following learning objectives for this webinar:
Describe the epidemiology of uncomplicated gonorrhea and DGI
Recognize the clinical manifestations of DGI and increase clinical suspicion for DGI in patients with joint pain
Demonstrate how to diagnose, manage, and treat DGI
Report all laboratory-confirmed and clinically-suspected cases of DGI to public health
Prioritize routine screening, testing, and treatment of STDs among high-risk patients
The Gonorrhea STD Module is a web-based training course designed to guide in the diagnosis, treatment, and prevention of gonococcal infections. CNE/CME credit is available.
A quick reference resource, it only lists the recommendations and data security guidelines included in the MMWR. The document is available in its entirety at www.cdc.gov/nchhstp/partners.
We support healthcare providers in the Western United States (AZ, CA, HI, NM, and NV) to improve clinical outcomes for those affected by sexually transmitted infections and HIV.
June 2, 2026
12:00PM-1:15 PM (PDT)
1.25 CME units offered at no cost
Registration closes on June 1, 2026 at 3:00PM (PDT)
Stay current on mpox!
This clinician-focused webinar reviews the latest U.S. and global epidemiology of mpox, including clade I. Learn how and when to suspect, diagnose, manage, and report mpox promptly and effectively. We’ll also translate the most recent vaccine recommendations into practical workflows during Pride Season and in preparation for summer travel and events.
Regional Training Center, National Network of STD Clinical Prevention (NNPTC)
Funded by the Centers for Disease Control and Prevention (CDC), CAPTC supports healthcare providers in the western United States (AZ, CA, HI, NM, and NV) to improve clinical outcomes for those affected by sexually transmitted infections and HIV.
We provide in-person and virtual training events, technical assistance, clinical tools, and STI clinical consultation (via the STD Clinical Consultation Network) to support providers in addressing the rise of STIs in their communities. We focus on complex issues in patient care including evolving PrEP modalities, congenital syphilis management and prevention, and complications of gonorrhea and chlamydia. Our faculty consists of physicians and nurses who are subject matter experts in the field of sexual health with extensive academic, clinical, and public health experience in STI control and response.
The CAPTC Clinical Program has been funded for over 30 years by the CDC and is part of the National Network of STD Clinical Prevention Training Centers (NNPTC). CAPTC also has a long-standing partnership with the California Department of Public Health (CDPH) STD Control Branch to deliver training on STI diagnosis and treatment to California counties experiencing high rates of STIs. CDPH and CAPTC regularly collaborate on issuing statewide guidance related to STI screening and treatment, as well as creating co-branded job aids and educational materials for providers throughout the state.
CAPTC is also proud to collaborate with San Francisco City Clinic (SFCC), San Francisco’s preeminent municipal STI clinic, to offer observerships in sexual health care. Clinicians interested in arranging a shadowing experience at SFCC of up to 4 half-days (which could potentially be structured to 2 full days, depending on the learner’s needs) can contact us at captc@ucsf.edu to learn more.
This service is intended for licensed healthcare professionals and STI public health program staff. We do not provide direct medical care, treatment planning or medical treatment services to individuals.
Looking to Build Your Clinical Skills?
Scroll down this page to check out our trainings on STIs, HIV, and other sexual health issues.
Contact us at captc@ucsf.edu if interested in learning about shadowing opportunities at San Francisco City Clinic.
January 2026. Developed in collaboration with Kristin Harter, PharmD at the University of California, San Francisco, this instructional video provides step-by-step guidance for adding lidocaine to Bicillin® L-A for the mitigation of pain during treatment of syphilis. This resource is intended for healthcare professionals who provide clinical care and are involved in the preparation and administration of these medications.
Designed to support clinicians and public health practitioners, this resource provides detailed algorithms for the evaluation, treatment, and follow-up of neonates, infants, and children exposed to syphilis during pregnancy. Developed in alignment with the 2021 CDC STI Treatment Guidelines, the resource outlines step-by-step instructions for monitoring RPR/VDRL titers, interpreting titer trends, and ensuring thorough follow-up care for infants and children affected by syphilis.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
